Published in FEBS J on December 01, 2008
Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet (2010) 4.26
Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic Biol Med (2012) 1.67
Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation. Neurodegener Dis (2010) 1.31
Cancer and neurodegeneration: between the devil and the deep blue sea. PLoS Genet (2010) 1.21
Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease. PLoS One (2011) 1.19
LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease. Neurogenetics (2009) 1.05
Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease. Hum Mol Genet (2014) 0.95
Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications. Mov Disord (2011) 0.95
LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models. J Mol Med (Berl) (2012) 0.88
Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease. Antioxid Redox Signal (2012) 0.88
Current understanding of LRRK2 in Parkinson's disease: biochemical and structural features and inhibitor design. Future Med Chem (2012) 0.86
Tau acts as an independent genetic risk factor in pathologically proven PD. Neurobiol Aging (2012) 0.86
Interaction of LRRK2 with kinase and GTPase signaling cascades. Front Mol Neurosci (2014) 0.82
TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPT. Neurobiol Aging (2013) 0.81
The pallidopyramidal syndromes: nosology, aetiology and pathogenesis. Curr Opin Neurol (2013) 0.76
Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson's Disease Assessed by the Unified Parkinson's Disease Rating Scale and the Hoehn-Yahr Stage. PLoS One (2016) 0.75
Computational Modelling Approaches on Epigenetic Factors in Neurodegenerative and Autoimmune Diseases and Their Mechanistic Analysis. J Immunol Res (2015) 0.75
Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus. Nat Commun (2011) 3.23
Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase. Proc Natl Acad Sci U S A (2008) 2.36
Mutations in LRRK2/dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1. J Neurochem (2007) 1.70
Cancer and neurodegeneration: between the devil and the deep blue sea. PLoS Genet (2010) 1.21
The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy. Nat Neurosci (2013) 1.19
Genetic neuropathology of Parkinson's disease. Int J Clin Exp Pathol (2008) 1.11
The metalloprotease inhibitor TIMP-3 regulates amyloid precursor protein and apolipoprotein E receptor proteolysis. J Neurosci (2007) 1.09
α-Synuclein mutations cluster around a putative protein loop. Neurosci Lett (2013) 1.00
A presenilin 1 mutation associated with familial frontotemporal dementia inhibits gamma-secretase cleavage of APP and notch. Neurobiol Dis (2002) 0.99
The R1441C mutation alters the folding properties of the ROC domain of LRRK2. Biochim Biophys Acta (2009) 0.98
Pathogenic LRRK2 mutations do not alter gene expression in cell model systems or human brain tissue. PLoS One (2011) 0.96
Creation of an open-access, mutation-defined fibroblast resource for neurological disease research. PLoS One (2012) 0.88
Dysfunction of the autophagy/lysosomal degradation pathway is a shared feature of the genetic synucleinopathies. FASEB J (2013) 0.88
LRRK2: cause, risk, and mechanism. J Parkinsons Dis (2013) 0.88
Pathogenic Parkinson's disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation. Biochem Biophys Res Commun (2013) 0.87
Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic cases. Neurobiol Dis (2013) 0.83
A tangled web - tau and sporadic Parkinson's disease. Front Psychiatry (2010) 0.83
Investigating the utility of human embryonic stem cell-derived neurons to model ageing and neurodegenerative disease using whole-genome gene expression and splicing analysis. J Neurochem (2012) 0.83
Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locus. PLoS One (2013) 0.82
GTP binding and intramolecular regulation by the ROC domain of Death Associated Protein Kinase 1. Sci Rep (2012) 0.81
GTP binding controls complex formation by the human ROCO protein MASL1. FEBS J (2013) 0.80
Rare variants in LRRK1 and Parkinson's disease. Neurogenetics (2013) 0.78
Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences. Brief Bioinform (2016) 0.75